Literature DB >> 8053487

High expression of the CD30 molecule in human decidual cells.

K Ito1, T Watanabe, R Horie, M Shiota, S Kawamura, S Mori.   

Abstract

CD30 is a receptor-type membrane protein that belongs to the nerve growth receptor superfamily. It is expressed on Hodgkin's cells and activated lymphocytes, as well as in some human malignancies including malignant lymphomas, embryonal carcinomas, and other mesenchymal tumors. However, whether it is expressed in normal tissues remains unclear. To study the expression and biological function of CD30, we first examined various human tissues by immunohistochemistry. The monoclonal antibody Ber-H2 intensely stained the membranes of decidual and endometrial cells with decidual change in frozen sections. Western blots of these tissues with Ber-H2 revealed bands of 120, 105, and 90 kd as found on CD30-expressing cells. Northern blots of these tissues using a CD30 cDNA probe detected mRNAs of the same molecular mass and variety as those in the positive control cell line HUT 102. These results indicated that CD30 is expressed in human endometrial tissue with decidual change and imply that CD30 expression in endometrial tissue is induced by hormonal control.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053487      PMCID: PMC1887376     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Biochemical and structural properties of a Hodgkin's disease-related membrane protein.

Authors:  J F Nawrocki; E S Kirsten; R I Fisher
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

3.  A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts.

Authors:  R Andreesen; J Osterholz; G W Löhr; K J Bross
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

4.  Evidence of Sternberg-Reed cells being derived from activated lymphocytes.

Authors:  H Stein; J Gerdes; H Lemke; D Y Mason
Journal:  Haematol Blood Transfus       Date:  1985

5.  Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells.

Authors:  U Schwab; H Stein; J Gerdes; H Lemke; H Kirchner; M Schaadt; V Diehl
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

6.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

7.  Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines.

Authors:  P Froese; H Lemke; J Gerdes; B Havsteen; R Schwarting; H Hansen; H Stein
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

8.  Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.

Authors:  M Rowe; C M Rooney; C F Edwards; G M Lenoir; A B Rickinson
Journal:  Int J Cancer       Date:  1986-03-15       Impact factor: 7.396

9.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

10.  Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.

Authors:  H Stein; J Gerdes; U Schwab; H Lemke; D Y Mason; A Ziegler; W Schienle; V Diehl
Journal:  Int J Cancer       Date:  1982-10-15       Impact factor: 7.396

View more
  8 in total

Review 1.  Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines.

Authors:  M P Piccinni; S Romagnani
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.

Authors:  U Latza; H D Foss; H Dürkop; F Eitelbach; K P Dieckmann; V Loy; M Unger; G Pizzolo; H Stein
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

3.  Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Jimmy Esoinoza; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Pooja Mittal; Eleazar Soto; Offer Erez; Shali Mazaki-Tovi; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-11

4.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

5.  Ber-H2 (CD30) immunohistochemical staining of human fetal tissues.

Authors:  D Tamiolakis; N Papadopoulos; M Lambropoulou; J Venizelos; D Verettas; P Tsikouras; G Koutsougeras; H Papadopoulos; A Karpouzis; C Kouskoukis
Journal:  Int J Biol Sci       Date:  2005-10-01       Impact factor: 6.580

6.  Design and Assessment of Novel Anti-CD30 Chimeric Antigen Receptors with Human Antigen-Recognition Domains.

Authors:  Stephanie Choi; Melissa A Pegues; Norris Lam; Claudia Geldres; Danielle Vanasse; James N Kochenderfer
Journal:  Hum Gene Ther       Date:  2021-02-22       Impact factor: 4.793

7.  Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.

Authors:  Demetrio Tamiolakis; John Venizelos; Maria Lambropoulou; Silva Nikolaidou; Sophia Bolioti; Maria Tsiapali; Dionysios Verettas; Panagiotis Tsikouras; Athanasios Chatzimichail; Nikolas Papadopoulos
Journal:  Theor Biol Med Model       Date:  2005-01-11       Impact factor: 2.432

8.  Study of the expression of CD30 in pterygia compared to healthy conjunctivas.

Authors:  Yonathan Garfias; Víctor Manuel Bautista-De Lucio; Cynthia García; Angel Nava; Leonardo Villalvazo; María Carmen Jiménez-Martínez
Journal:  Mol Vis       Date:  2009-10-17       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.